SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-21-001119
Filing Date
2021-11-30
Accepted
2021-11-30 16:18:25
Documents
14
Period of Report
2021-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 22370
2 PRESS RELEASE opgen_ex99z1.htm EX-99.1 14027
3 GRAPHIC image_001.jpg GRAPHIC 3169
  Complete submission text file 0001553350-21-001119.txt   217527

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20211130.xsd EX-101.SCH 3019
5 XBRL LABEL FILE opgn-20211130_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE opgn-20211130_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3563
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 211459897
SIC: 8071 Services-Medical Laboratories